Skip to main content
editorial
. 2019 Aug 8;6(5):e599. doi: 10.1212/NXI.0000000000000599

Figure. Concept for use of serum/plasma NfL for individual therapeutic decision making in MS.

Figure

DMT = disease-modifying therapy; NfL = neurofilament light chain.